GlassScriptPhysician profile
Masood Ahmed
NPI 1093796310
$2,611.85
in general payments reported to CMS, 2019-2025
23 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $365 · 2021: $366 · 2022: $359 · 2023: $316 · 2024: $358 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $476.73 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $347.20 | 2020-2024 | Xarelto |
| Amgen INC. | $320.28 | 2019-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $260.42 | 2019-2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $223.58 | 2019-2024 | |
| Philips North America LLC | $160.09 | 2020-2025 | Extended Holter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.23 | 2019-2023 | Jardiance |
| Scpharmaceuticals INC. | $95.12 | 2025 | |
| Astellas Pharma US INC | $79.57 | 2019 | |
| Biotronik INC. | $59.94 | 2022 | |
| Pfizer INC. | $59.04 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $57.13 | 2020-2024 | |
| Braemar Manufacturing, LLC | $46.28 | 2019 | |
| Novo Nordisk INC | $39.76 | 2024 | Ozempic, Rybelsus |
| Medicomp INC | $37.30 | 2024 | Telepatch Cardiac Monitor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $34.43 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $30.22 | 2020-2024 | Opsumit, Uptravi |
| Shockwave Medical, INC | $26.13 | 2025 | |
| Bardy Diagnostics, INC. | $24.55 | 2021 | |
| Medtronic Vascular, INC. | $23.56 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $20.48 | 2024 | Arcalyst |
| Preventice Services, LLC | $17.08 | 2021 | |
| Medtronic, INC. | $15.73 | 2023 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Masood Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.